The Indonesian Directorate General of Customs and Excise (DJBC) has stated that the consumption tax revenue from new tobacco products in the country is expected to reach 1.02 trillion Indonesian rupiah (approximately $6.68 million USD) in 2022. This figure amounts to only 0.4% of the total consumption tax revenue for that year.
According to data from the Ministry of Finance, Indonesia is projected to generate tariff and consumption tax revenue of 317.8 trillion Indonesian rupiah (equivalent to $20.8 billion USD) in 2022. The total consumption tax on tobacco products alone is estimated to reach 218.62 trillion Indonesian rupiah (equivalent to $14.3 billion USD).
The consumption tax for the new tobacco products is 1.02 trillion Indonesian rupiah (approximately $66.8 million USD), which is divided into three categories: closed-system electronic cigarettes with a revenue of 119.47 billion Indonesian rupiah (approximately $7.82 million USD), heat-not-burn products with a revenue of 271.93 billion Indonesian rupiah (approximately $17.81 million USD), and open-system products with a revenue of 627.11 billion Indonesian rupiah (approximately $4.1 million USD).
References:
The realization of electronic cigarette tax in 2022 is only Rp 1.02 trillion.
Disclaimer
This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.
Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.
The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.
This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.
Copyright Notice
This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.
No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.
For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.
AI-Assisted Translation and Editing Notice
Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.
Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.
